Cargando…
Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management
Since its discovery in England and France in 1986, vancomycin-resistant Enterococcus has increasingly become a major nosocomial pathogen worldwide. Enterococci are prolific colonizers, with tremendous genome plasticity and a propensity for persistence in hospital environments, allowing for increased...
Autores principales: | O’Driscoll, Tristan, Crank, Christopher W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521680/ https://www.ncbi.nlm.nih.gov/pubmed/26244026 http://dx.doi.org/10.2147/IDR.S54125 |
Ejemplares similares
-
Intravitreal linezolid in the management of vancomycin-resistant enterococcal endophthalmitis
por: Babalola, Olufemi Emmanuel
Publicado: (2020) -
Post-traumatic vancomycin-resistant enterococcal endophthalmitis
por: Hillier, Roxane J, et al.
Publicado: (2013) -
Vancomycin-resistant Enterococcal Bacteremia in a Hematology Unit: Molecular Epidemiology and Analysis of Clinical Course
por: Yoo, Jin-Hong, et al.
Publicado: (2005) -
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019) -
1045 Linezolid Compared to Daptomycin for the Treatment of Vancomycin-resistant Enterococcal Urinary Tract Infections
por: Moenster, Ryan P., et al.
Publicado: (2014)